REGN-1400
Product Specifications
Target
EGFR
Related Pathways
JAK/STAT signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
REGN-1400 is a fully human monoclonal antibody inhibitor targeting ErbB3. By inhibiting ErbB3, REGN-1400 blocks associated signaling pathways to reduce tumor cell proliferation. It shows potential for research in solid tumors such as non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and squamous cell carcinoma of the head and neck (SCCHN) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3737903 1.0 µg DNA
Zbtb46 sgRNA CRISPR Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details 
MBS1083179-01 0.02 mg (E-Coli)
Recombinant Streptococcus sanguinis tRNA-specific 2-thiouridylase mnmA (mnmA)
Sign In for Pricing
View Details 
MBS1083179-02 0.02 mg (Yeast)
Recombinant Streptococcus sanguinis tRNA-specific 2-thiouridylase mnmA (mnmA)
Sign In for Pricing
View Details